Relationship Between Dipper/Non-Dipper Pattern and Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Geriatric Patients with Hypertension

Abstract

Objective: Neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) are inflammatory markers associated with poor prognoses. Non-dipper hypertension (HT) is linked to a higher risk for cardiovascular events. This study aims to investigate the association between NLR and PLR in geriatric patients with dipper and non-dipper HT. Materials and Methods: A total of 124 geriatric patients with HT were included in the study. Based on ambulatory blood pressure monitoring, patients were categorized into two groups: non-dippers (n=62, Group 1) and dippers (n=62, Group 2). NLR and PLR were calculated by dividing the absolute neutrophil and platelet counts, respectively, by the absolute lymphocyte count. Results: There were no significant differences in sex, age, chronic conditions and smoking between the two groups (p>0.005). The NLR was 1.96±0.66 in group 1 and 1.67±0.68 in group 2 (p:0.005). The PLR was 146±42.2 in group 1 and 115±34.2 in group 2 (p:0.001). The NLR and PLR were significantly higher in non-dippers compared to dippers (p<0.005). Conclusion: Our findings demonstrate that geriatric patients with non-dipper HT have significantly higher NLR and PLR compared to those with dipper HT. This suggests that non-dipper HT is associated with greater inflammation, which may contribute to its higher cardiovascular risk.

Keywords

• Dipper
• geriatric patients
• NLR
• non dipper
• PLR

Hipertansiyonu Olan Geriatrik Hastalarda Dipper/Non-Dipper Paterni ile Nötrofil-Lenfosit Oranı ve Trombosit-Lenfosit Oranı arasındaki İlişki

Öz

Amaç: Nötrofil lenfosit (NLR) ve trombosit lenfosit oranı (PLR), kötü prognozu gösteren bir inflamatuar belirteçtir. Non-dipper hipertansiyon, kardiyovasküler olaylar için daha yüksek risk ile ilişkilidir. Bu çalışmanın amacı, dipper ve non-dipper hipertansiyonu olan hastalarda NLR ve PLR arasındaki ilişkiyi araştırmaktır. Materyal ve Metot: Çalışmaya hipertansiyonu olan 124 geriatrik hasta dahil edildi. Hastalar ambulatuvar kan basıncı ölçümüne göre non-dipper (n:62, grup 1) ve dipper (n:62, grup 2) olmak üzere iki gruba ayrıldı. Nötrofil lenfosit (NLR) ve trombosit lenfosit oranı (PLR), mutlak nötrofil sayısı ve trombosit sayısının mutlak lenfosit sayısına bölünmesiyle hesaplandı. Bulgular: İki grup arasında cinsiyet, yaş, kronik hastalıklar e sigara içiciliği açısından anlamlı fark yoktu (p>0,005). Kronik hastalıklar ve sigara kullanımı açısından da anlamlı fark yoktu. NLR grup 1'de 1,96±0,66 iken grup 2'de 1,67±0,68 idi (p:0,005). PLR grup 1'de 146±42,2 iken grup 2'de 115±34,2 idi (p:0,001). Sonuç: Bulgularımız non-dipper HT'li geriatrik hastaların, dipper HT'li hastalara göre anlamlı derecede daha yüksek NLR ve PLR'ye sahip olduğunu göstermektedir. Bu, non-dipper HT'nin daha yüksek inflamasyonla ilişkili olduğunu ve bunun da daha yüksek kardiyovasküler riske katkıda bulunabileceğini göstermektedir.

Anahtar Kelimeler

• Dipper
• geriatrik hastalar
• NLR
• non dipper
• PLR

References

1. 1- Nurkoç SG, Yakışan T. Mean platelet volume/platelet count ratio and dipper/non-dipper hypertensive patients. Angiology. 2024;22:33197241274825. doi:10.1177/00033197241274825
2. 2- Tosu AR, Demir S, Selcuk M, et al. Comparison of inflammatory markers in non-dipper hypertension vs. dipper hypertension and in normotensive individuals: uric acid, C reactive protein and red blood cell distribution width readings pwki. 2014; 2:98-103.
3. 3- Sarma J, Laan CA, Alam S, et al. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002;105:2166e71.
4. 4- Islam MM, Satici MO, Eroglu SE. Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review. Turk J Emerg Med. 2024;8;24:8-19. doi:10.4103/tjem.tjem_198_23
5. 5- Wu CC, Wu CH, Lee CH, et al. Association between neutrophil percentage-to-albumin ratio (NPAR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and long-term mortality in community-dwelling adults with heart failure: evidence from US NHANES 2005-2016. BMC Cardiovasc Disord. 2016;21:312. doi:10.1186/s12872-023-03316-6
6. 6- Selvaggio S, Abate A, Brugaletta G, et al. Platelet to lymphocyte ratio, neutrophil to lymphocyte ratio and monocyte to HDL cholesterol ratio as markers of peripheral artery disease in elderly patients. Int J Mol Med. 2020;46:1210-1216. doi:10.3892/ijmm.2020.4644
7. 7- Salciccia S, Frisenda M, Bevilacqua G, et al. Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review. Asian J Urol. 2024;11:191-207. doi: 10.1016/j.ajur.2023.01.002
8. 8- Varim C, Celik F, Sunu C, et al. Inflammatory cell ratios in the patients with fibromyalgia. Georgian Med News. 2021;315:108-113.

9. 9- Wang H, Hu Y, Geng Y, et al. The relationship between neutrophil to lymphocyte ratio and artery stiffness in subtypes of hypertension. J Clin Hypertens (Greenwich). 2017;19:780-785. doi:10.1111/jch.13002
10. 10- Jhuang YH, Kao TW, Peng TC, et al. Neutrophil to lymphocyte ratio as predictor for incident hypertension: a 9-year cohort study in Taiwan. Hypertens Res. 2019;42:1209-1214. doi:10.1038/s41440-019-0245-3
11. 11- Tatsukawa Y, Hsu WL, Yamada M,et al. White blood cell count, especially neutrophil count, as a predictor of hypertension in a Japanese population. Hypertens Res. 2008;31:1391-1397. doi:10.1291/hypres.31.1391
12. 12- De Servi S, Landi A, Gualini E,et al. Neutrophil count as a risk factor for cardiovascular diseases: how can we manage it? J Cardiovasc Med (Hagerstown). 2024;25:759-765. doi:10.2459/JCM.0000000000001668
13. 13- De Servi S, Landi A, Gualini E, et al. Neutrophil count as a risk factor for cardiovascular diseases: how can we manage it? J Cardiovasc Med (Hagerstown). 2024;25:759-765. doi:10.2459/JCM.0000000000001668
14. 14- Núñez J, Miñana G, Bodí V, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18:3226-3233. doi:10.2174/092986711796391633
15. 15- Ferroni P, Vazzana N, Riondino S, et al. Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal. 2012;17:1447-1485. doi:10.1089/ars.2011.4324
16. 16- Amraotkar AR, Song DD, Otero D, et al. Platelet count and mean platelet volume at the time of and after acute myocardial ınfarction. Clin Appl Thromb Hemost. 2017;23:1052-1059. doi:10.1177/1076029616683804
17. 17- Nalbant A, Kaya T, Varim C, et al. Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)? Rev Assoc Med Bras (1992). 2020;66:746-751. doi:10.1590/1806-9282.66.6.746
18. 18- Cengiz H, Varim C, Demirci T, et al. Hemogram parameters in the patients with subacute thyroiditis. Pak J Med Sci. 2020;36:240-245. doi:10.12669/pjms.36.2.1063
19. 19- Cupp MA, Cariolou M, Tzoulaki I, et al. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18:360. doi:10.1186/s12916-020-01817-1. PMID: 33213430; PMCID: PMC7678319
20. 20- Zhang X, Wei R, Wang X, et al. The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension. Cardiovasc Diabetol. 2024;23:117. doi:10.1186/s12933-024-02191-5
21. 21- Pruc M, Peacock FW, Rafique Z,et al. The Prognostic Role of Platelet-to-Lymphocyte Ratio in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12:6903. doi:10.3390/jcm12216903
22. 22- Vakhshoori M, Bondariyan N, Sabouhi S,et al. The impact of platelet-to-lymphocyte ratio on clinical outcomes in heart failure: a systematic review and meta-analysis. Ther Adv Cardiovasc Dis. 2024;18:17539447241227287. doi:10.1177/17539447241227287
23. 23- Meng X, Sun H, Tu X, et al. The Predictive Role of Hematological Parameters in Hypertension. Angiology. 2024;75:705-716. doi: 10.1177/00033197231190423
24. 24- Uzun F, Erturk M, Cakmak HA, et al. Usefulness of the platelet-to-lymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease. Postepy Kardiol Interwencyjnej. 2017;13:32-38. doi:10.5114/aic.2017.66184